Jing Wang

Jing Wang

Auto-generated profile, based on publicly available information

Jing Wang

Department of Pathology Peking Union Medical College Hospital Beijing China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2022 in Cancer Communications
Verified
Journal Article
Open access
HWHuanwen Wu
Huanwen Wu
ZYZicheng Yu
Zicheng Yu
YLYueping Liu
Yueping Liu
LGLei Guo
Lei Guo
LTLianghong Teng
Lianghong Teng
ZLZhiyong Liang
Zhiyong Liang
Background: Neuroendocrine carcinomas of the gastrointestinal tract (GI‐NECs) remain a disease of grim prognosis with limited therapeutic options. Their molecular characteristics are still undefined. This study aimed to explore the underlying genetic basis and heterogeneity of GI‐NECs. Methods: Comprehensive genomic analysis using whole‐exome sequencing was performed on 143 formalin‐fixed, paraffin‐embedded samples of surgically resected GI‐NEC with a thorough histological evaluation. Mutational signatures, somatic mutations, and copy number aberrations were analyzed and compared across anatomic locations and histological subtypes. Survival analysis was conducted to identify the independent factors. Results: In total, 143 GI‐NECs were examined: the stomach, 87 cases (60.8%); the esophagus, 29 cases (20.3%); the colorectum, 20 cases (14.0%); and the small intestine, 7 cases (4.9%). Eighty‐three (58.0%) and 60 (42.0%) cases were subclassified into small cell and large cell subtypes, respectively. GI‐NECs showed distinct genetic alterations from their lung counterparts and non‐neuroendocrine carcinomas in the same locations. Obvious heterogeneity of mutational signatures, somatic mutations, and copy number variations was revealed across anatomic locations rather than histological subtypes. Except for tumor protein p53 ( TP53 ) and retinoblastoma 1 ( RB1 ), the most frequently mutated genes in the stomach, esophagus, colorectum, and small intestine were low‐density lipoprotein receptor‐related protein 1B ( LRP1B ), notch receptor 1 ( NOTCH1 ), adenomatosis polyposis coli ( APC ), catenin beta 1 ( CTNNB1 ), respectively. Mutations in the WNT‐β‐catenin, NOTCH and erythroblastic leukemia viral oncogene B (ERBB) pathways were prevalently identified in gastric, esophageal, and colorectal NECs, respectively. Importantly, 104 (72.7%) GI‐NECs harbored putative clinically relevant alterations, and non‐gastric location and RB1 bi‐allelic inactivation with copy number alterations were identified as two independent poor prognostic factors. Furthermore, we found that tumor cells in GI‐NECs first gain clonal mutations in TP53 , RB1 , NOTCH1 and APC , followed by subsequent whole‐genome doubling (WGD) and post‐WGD clonal mutations in LRP1B , CUB and Sushi multiple domains 3 ( CSMD3 ), FAT tumor suppressor homolog 4 ( FAT4 ) and erb‐b2 receptor tyrosine kinase 4 ( ERBB4 ), and finally develop subclonal mutations. Conclusions: GI‐NECs harbor distinct genomic landscapes and demonstrate significant genetic heterogeneity across different anatomic locations. Moreover, potentially actionable alterations and prognostic factors were revealed for GI‐NECs.

20 May 2024 in International Journal of Cancer
Verified
Journal Article
Open access
XCXiaopei Chao
Xiaopei Chao
ZKZhentian Kai
Zhentian Kai
HWHuanwen Wu
Huanwen Wu
JWJing Wang
Jing Wang
XCXiaojing Chen
Xiaojing Chen
LLLei Li
Lei Li
Ovarian cancer (OC) is a major cause of cancer mortality in women worldwide. Due to the occult onset of OC, its nonspecific clinical symptoms in the early phase, and a lack of effective early diagnostic tools, most OC patients are diagnosed at an advanced stage. In this study, shallow whole‐genome sequencing was utilized to characterize fragmentomics features of circulating tumor DNA (ctDNA) in OC patients. By applying a machine learning model, multiclass fragmentomics data achieved a mean area under the curve (AUC) of 0.97 (95% CI 0.962–0.976) for diagnosing OC. OC scores derived from this model strongly correlated with the disease stage. Further comparative analysis of OC scores illustrated that the fragmentomics‐based technology provided additional clinical benefits over the traditional serum biomarkers cancer antigen 125 (CA125) and the Risk of Ovarian Malignancy Algorithm (ROMA) index. In conclusion, fragmentomics features in ctDNA are potential biomarkers for the accurate diagnosis of OC.

17 July 2025 in Laboratory Investigation
Verified
Journal Article
Closed access
JWJing Wang
Jing Wang
YCYumeng Cai
Yumeng Cai
JWJun Wang
Jun Wang
JFJiuyuan Fang
Jiuyuan Fang
JPJunyi Pang
Junyi Pang
ZLZhiyong Liang
Zhiyong Liang

1 June 2021 in Research Square
Verified
Preprint
Open access
PDF file
JWJing Wang
Jing Wang
RLRuiyu Li
Ruiyu Li
JLJunjie Li
Junjie Li
YYYuting Yi
Yuting Yi
XLXiaoding Liu
Xiaoding Liu
ZLZhiyong Liang
Zhiyong Liang
Background: Colorectal carcinoma (CRC) harboring oncogenic fusions has been reported to be highly enriched in mismatch repair deficient (dMMR) tumors with MLH1 hypermethylation (MLH1me+) and wild-type BRAF and RAS. In this study, dMMR CRCs were screened for oncogene fusions using sequential DNA and RNA next generation sequencing (NGS). Results: Comprehensive analysis of fusion variants, genetic profiles and clinicopathological features in fusion-positive dMMR CRCs was performed. Eighteen fusion-positive cases were identified by DNA NGS in 193 consecutive dMMR CRCs in Peking Union Medical College Hospital, all of which were MLH1me+ and BRAF/RAS wild-type. RNA NGS was sequentially conducted in 21 MLH1me+ BRAF/RAS wild-type dMMR CRCs lacking oncogenic fusions by DNA NGS, and revealed four additional fusions, increasing the proportion of fusion-positive tumors from 46% (18/39) to 56% (22/39) in MLH1me+ BRAF/RAS wild-type dMMR cases. All 22 fusions were found to involve RTK-RAS pathway. Most fusions affected targetable receptor tyrosine kinases, including NTRK1(9/22, 41%), NTRK3(5/22, 23%), ALK(3/22, 14%), RET(2/22, 9%) and MET(1/22, 5%), whilst only two fusions affected mitogen-activated protein kinase cascade components BRAF and MAPK1, respectively. RNF43 was identified as the most frequently mutated genes, followed by APC, TGFBR2, ATM, BRCA2 and FBXW7. The vast majority (19/22, 86%) displayed alterations in key WNT pathway components, whereas none harbored additional mutations in RTK-RAS pathway. In addition, fusion-positive tumors were typically diagnosed in elder patients and predominantly right-sided, and showed a significantly higher preponderance of hepatic flexure localization (P<0.001) and poor differentiation (P=0.019), compared to fusion-negative MLH1me+ CRCs. Conclusions: We proved that sequential DNA and RNA NGS was highly effective for fusion detection in dMMR CRCs, and proposed an optimized practical fusion screening strategy. We further revealed that dMMR CRCs harboring oncogenic fusion was a genetically and clinicopathologically distinctive subgroup, and justified more precise molecular subtyping for personalized therapy.

11 June 2026 in International Journal of Cancer
Verified
Journal Article
Closed access
XZXiaoying Zhong
Xiaoying Zhong
XJXitong Jin
Xitong Jin
YCYanan Cheng
Yanan Cheng
XCXiaopei Chao
Xiaopei Chao
LKLinghua Kong
Linghua Kong
LLLei Li
Lei Li